Showing results (51-60 of 148) with videos related to
Sort By:
Pageof 15
Circulation|April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT TrialAntonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.The American Journal of Cardiology|March 4, 2014
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)Benoit J Arsenault, S Matthijs Boekholdt, Samia Mora, et al.Journal of the American College of Cardiology|November 7, 2006
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) studyDavid D Waters, John C LaRosa, Philip Barter, et al.Atherosclerosis|February 7, 2012
Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development programEvan A Stein, Donald G Vidt, James Shepherd, et al.Journal of Environmental Management|October 3, 2021
Mapping bare ground in New Zealand hill-country agriculture and forestry for soil erosion risk assessment: An automated satellite remote-sensing methodHeather North, Alexander Amies, John Dymond, et al.Atherosclerosis|August 15, 2016
Dyslipidaemia in the Middle East: Current status and a call for actionKhalid Al Rasadi, Wael Almahmeed, Khalid F AlHabib, et al.Journal of Clinical Lipidology|February 12, 2015
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trialEliot A Brinton, Uma Kher, Sukrut Shah, et al.International Journal of General Medicine|July 28, 2018
Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle EastMostafa Alshamiri, Mahmood Mohammed Ali Ghanaim, Philip Barter, et al.Diabetes Research and Clinical Practice|July 12, 2011
Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: what we know and don't knowJuliana C N Chan, Siew Pheng Chan, Chaicharn Deerochanawong, et al.Journal of Lipid Research|November 23, 2012
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapibMichael Davidson, Sherry Xueyu Liu, Philip Barter, et al.Pageof 15